Clinical Performance of the Aptima CMV Quant Assay on the Panther System

Recruiting
99 years or below
All
20 participants needed

Brief description of study

The purpose of this study is to look at the effectiveness of an investigational test called the Aptima CMV Quantification Diagnostic Assay (Aptima CMV Quant Assay) to measure levels of CMV in plasma. The target population is subjects who have tested positive for cytomegalovirus (CMV) after receiving a solid-organ transplant or stem cell transplant. This is a non-interventional study. The main study procedure is the collection of an extra tube of blood when subjects are having routine standard of care CMV testing performed at UPenn.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: CMV
  • Age: 99 years or below
  • Gender: All
Updated on 19 Feb 2024. Study ID: 833533

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.